Pharm 411 Medical Devices Overview of Device Regulations

Slides:



Advertisements
Similar presentations
Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.
Advertisements

Sorenson Medical, West Jordan, Utah USA Medical Device Development Robert Hitchcock, Ph.D. Director of Engineering & Technology Development Sorenson Medical,
Regulatory Pathway for Platform Technologies
Entering the US Market: Medical Devices
Overview of FDA Device Regulations
Food Advisory Committee Meeting Risk assessments and susceptible life stages and populations December 16, 2014 Rachel Osterman Associate Chief Counsel,
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
Humanitarian Device Exemptions (HDE) 101 Elizabeth Hillebrenner, MSE Biomedical Engineer IDE and HDE Program Staff Center for Devices and Radiological.
510k Submission Overview Myraqa, Inc. August 22, 2012.
Introduction to Regulation
Medical Device Submissions
University of Medicine and Dentistry of New Jersey John L. Ricci, Ph.D., Department of Orthopaedics History and Scope of Biomaterials J. L. Ricci, Ph.D.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Medical Devices Approval Process
Article 42. – Emergency Safety Interventions ESI Regulations K.A.R and As Passed by the Kansas State Board of Education 2.
Donna M. Liewer FCLB Executive Director Understanding the FDA: Key Considerations for Regulatory Agencies.
Cross-Labeling: Legal and Regulatory Issues David M. Fox Hogan & Hartson LLP th Street, NW Washington, DC
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
Team SaltronTM October 25th, 2010
Basic Principles of FDA Medical Device Regulation and How FDA Might Have Handled the Recent PIP Crisis British Institute of International and Comparative.
Presented by: George Howe Executive Vice President Business Development & OEM Accounts.
Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
Patient Safety and Medical Devices Sonia Swayze, RN, MA, C and Suzanne Rich, RN, MA, CT.
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
Medical Devices IRB Determination IRB Member Continuing Education.
Regulatory Primer 101 Patrick Kennelly, Chief Food Safety Section California Department of Public Health March 11, 2014.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
Module 1.  Objectives - Provide information about worker rights under OSHA law - Learn how to file a complaint, and rights against discrimination and.
510(k) Process: Best Practices in Changing Times… MassMEDIC Massachusetts Medical Society, Waltham, MA April 1, :00 AM - 10:30 AM.
Food and Drug Administration Kevin Bedal, Lisa Carlin, Matt Carroll, Erin Nichols October 24 th, 2011.
Latham & Watkins operates as a limited liability partnership worldwide with affiliated limited liability partnerships conducting the practice in the United.
COMPLIANCE ACTIONS FDA Regulation & Licensure of Whole Blood & Blood Components, Including Source Plasma September 15-16, 2009 Helen Cowley Office of Compliance.
Humanitarian Use Devices September 23, 2011 Theodore Stevens, MS, RAC Office of Cellular, Tissue and Gene Therapies Center for Biologics Evaluation and.
1 Politics of Tobacco Regulation FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120 (U.S. 2000)
Center for Drug Evaluation and Research (CDER) Tanya Eberle Kamal Diar David Clements.
Food and Drug Administration Michael Jordan and Jeff Beegle October 23 nd, 2013.
REGULATION OF COMBINATION PRODUCTS Mark A. Heller Wilmer Cutler Pickering Hale and Dorr LLP MassMEDIC Combination Product Program, March 28, 2006.
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
The Food and Drug Administration Allison Kotchman Victoria Gilbride.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
Mammography Regulations and Standards in the U.S.: The Basics of the Mammography Quality Standards Act Helen J. Barr, MD Director, Division of Mammography.
Moj Eram, PhD Senior Consultant ARC Experts, LLC 6 April, 2016
Regulation of Medical Devices: Tanzania experience Fimbo, A. M Tanzania Food and Drugs Authority.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
Device regulations USA Dr Phil Warner. USA Regulations MEDICAL DEVICES Food, Drug & Cosmetics Act Medical Device Amendments of 1976 (and other things)
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
Executive Director, Registrar Corp
GCP AND MEDICAL DEVICES
The Food and Drug Administration
Division of Cardiovascular Devices
U.S. FDA Center for Devices and Radiological Health Update
Premarket Notification 510(k) process
Overview of regulatory and compliance in software development for medical devices
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
FDA Resources and Meetings
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Opening an IND: Investigator Perspective
Presentation transcript:

Pharm 411 Medical Devices Overview of Device Regulations Tom Hazlet Pharmaceutical Outcomes Research & Policy Program 13 April 2005

Menu Regulatory Stuff: definitions, history “To market, to market …” and device classification Where to look for information Questions – whenever With thanks to Dave Pettenski, USFDA, from whose material much of this talk was poached.

FDA Center for Medical Devices and Radiological Health (CDRH) firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. radiation emitting electronic products (medical and non-medical) such as lasers, x-ray systems, ultrasound equipment, microwave ovens and color televisions. www.fda.gov/cdrh

FDA Definition of “medical device” (h) The term ''device'' … means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is - (1) recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them, (2) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or (3) intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.

FDA History - Medical Device Amendments of 1976 1969 HEW survey:10 years 10,000 injuries & 751 fatalities FDA survey: 858 deaths Independent survey 36,000 complications in one year B. Medical Device Amendments of 1976 1969 HEW survey revealed in 10 years 10,000 injuries & 751 fatalities FDA survey 858 deaths associated with medical devices Independent survey noted 36,000 complications in one year with use of medical devices Dalkon Shield, an IUD, marketed w/o proper testing resulted in removal rate of 26.4%, an infection rate of 5%, 25 miscarriages and 16 deaths Cardiac pacemakers defects necessitated 30 recalls involving 23,000 units These statistics heightened congressional awareness for more effective control of medical devices to ensure public health protection May 28, 1976 President Ford signed into law the Medical Device Amendments to the Act

FDA History - Medical Device Amendments of 1976 Dalkon Shield, an IUD, marketed w/o proper testing: removal rate of 26.4% an infection rate of 5% 25 miscarriages, 16 deaths Cardiac pacemakers defects necessitated 30 recalls involving 23,000 units May 28, 1976

FDA History - Medical Device Amendments of 1976 Key features of the 1976 Amendments Classification for regulatory purposes Pre-market approval: implanted & life supporting devices Interstate commerce is presumed in all cases Authority to issue GMP's, Access to industry records Registration and list, Authority to ban devices Key features of the 1976 Amendments Medical Devices classified for regulatory purposes Premarket approval for all implanted and life supporting devices FDA does not have to show imminent hazard to remove a device from market, just that the device presents a substantial deception or a substantial & unreasonable risk Administrative detention for 30 days Manufacturers can be required to notify the public of a product defect that could be a health hazard. Repair, replace or refund the cost of defective devices Interstate commerce is presumed in all cases FDA can limited distribution of certain devices (Restricted/Rx) FDA has authority to issue GMP's Access to industry records Registration and list Authority to ban devices

FDA History Safe Medical Devices Act of 1990 Post-Market Surveillance Enforcement Provisions Establishes Office of International Relations for harmonization GMP now includes Pre-production Design control requirements (QSR) D. Safe Medical Devices Act of 1990 Pre-Market Provisions Post-Market Surveillance User Reporting Distributor Reporting of MDR's Annual Certification of Device Reporting Device Tracking Reports of Removals and Corrections to FDA Required surveillance for devices: implants/life supporting/sustaining Enforcement Provisions New section on Recall Authority Temporary suspension of PMA Approval Civil Penalties Establishes Office of International Relations for harmonization GMP now includes Pre-production Design control requirements (QSR)

FDA History MDUFMA: The Medical Device User Fee and Modernization Act of 2002 Amends the Federal FD & C Act - signed into law October 26, 2002. User fees for device reviews. Establishment inspections may be conducted by accredited persons (third-parties), New regulatory requirements for reprocessed single-use devices.

Basic Device Regulatory Requirements Premarket Notification 510(k), unless exempt, or Premarket Approval (PMA), Establishment registration Medical Device Listing Quality System (QS) regulation, Labeling requirements, and Medical Device Reporting (MDR)

FDA “powers” If FD&C Act/regulations are not followed the result is a Prohibited Act adulteration misbranding Sanctions Non-regulatory (meeting, untitled letter, warning letter, civil penalties) Judicial Actions (seizure, injunction, prosecution; successful enforcement actions) Criminal prosecution

Compliance Officer Review Case Flow Dept. of Justice (DOJ) Asst. U.S. Attorney (Seizures) Inspection Compliance Officer Review Center Compliance Review CDRH/CDER/CBER Office of Chief Counsel (OCC) Administrative Law Judge (ALJ) Legal Office of Enforcement (OE) Div Comp Mgt & Ops. (DCMO) District Office Supervisor Review FDA Hdqts. Office

Medical Device Classification & Regulatory Requirements Class I - General Controls (with & w/o exemptions) Class II – General Controls and Special Controls (with & w/o exemptions) Class III – General Controls and Premarket Approval

Examples of Class I Devices Examination Gloves 21CFR880.6250 Dental Hand Instrument 21CFR872.4565 Elastic Bandages 21CFR880.5075 Pacemaker Charger 21CFR870.3670 Ultrasonic Cleaner for Medical Instruments 21CFR880.6150 Hand-held (Manual) Surgical Instruments 21CFR878.4800

Class II - Special Controls General Controls alone are insufficient to provide assurance of Safety & Effectiveness BUT Information exists to establish Special Controls

Special Controls General Controls + Special Labeling Requirements Performance Standards Postmarket Surveillance Patient Registries Guidelines Recommendations Any other appropriate actions

Examples of Class II Devices Cardiac Monitor 21CFR870.2300 Elbow Joint Metal/Polymer Constrained Cemented Prosthesis 21CFR888.3150 Pediatric hospital bed 21CFR880.5140 Infusion Pump 21CFR880.5725 Powered Wheelchair 21CFR890.3860 Surgical Drapes 21CFR878.4370 TENS device 21CFR882.5890

Class III - Premarket Approval Not enough information to classify as either Class I or II Device usually supports/sustains life, is of substantial importance in preventing impairment of human health or presents a potential, unreasonable risk of illness or injury

Premarket Approval Extensive submission including data showing Safety & Effectiveness Conditions of Approval Annual Reports

Examples of Class III Devices Implantable 21CFR870.3610 Replacement heart valve 21CFR870.3925 Cranial electrotherapy 21CFR882.5800 Implanted electrical urinary continence device 21CFR876.5270 Silicone gel-filled breast implant 21CFR878.3540 Implanted cerebella stimulator 21CFR882.5820

Device Classification – risk-based Roughly 1700 different device types 16 Medical Specialties Class Approval Prior to Marketing Example I Generally exempt Wheelchair II 510(k) substantially equivalent Oxygen generator, portable III Premarketing Agreement (PMA) Electroconvulsive therapy device

Where to find information FDA web site  CDRH  “Device Advice”  “Classify your device” find “PRODUCT CODE CLASSIFICATION DATABASE” select “Go to simple search” enter product name – “pregnancy test kit” select hot link select CFR citation

Find Info - 2 “performance standards” – vestige of ’76 Act that has never been completed for many products, see specific information in CFR, or Guidance Documents CDRH  “search guidance database”  do “simple search”

Class I – Wheelchair … but compare: Sec. 890.3880 Special grade wheelchair

Class II – Oxygen Generator

Class III – Electroconvulsive therapy device

Durable Medical Equipment Social Security Act Section 1861(n) – DHHS | CMS (n) The term “durable medical equipment” includes iron lungs, oxygen tents, hospital beds, and wheelchairs (which may include a power-operated vehicle that may be appropriately used as a wheelchair, but only where the use of such a vehicle is determined to be necessary on the basis of the individual's medical and physical condition and the vehicle meets such safety requirements as the Secretary may prescribe) used in the patient's home (including an institution used as his home other than an institution that meets the requirements of subsection (e)(1) of this section or section 1819(a)(1)), whether furnished on a rental basis or purchased, and includes blood-testing strips and blood glucose monitors for individuals with diabetes without regard to whether the individual has Type I or Type II diabetes or to the individual's use of insulin (as determined under standards established by the Secretary in consultation with the appropriate organizations); except that such term does not include such equipment furnished by a supplier who has used, for the demonstration and use of specific equipment, an individual who has not met such minimum training standards as the Secretary may establish with respect to the demonstration and use of such specific equipment. With respect to a seat-lift chair, such term includes only the seat-lift mechanism and does not include the chair. http://www.cms.hhs.gov/suppliers/dmepos/

Home Test Kits 500+ Most – diabetes – associated Pregnancy, ovulation Fecal occult blood, colon cancer “drug” testing

Ostomy Supplies

Questions